AI text messages to help your heart health
Part of Heart & circulation clinical trials.
This study tests if text messages from an AI program can help you improve your heart health habits, like taking medication on time and managing blood pressure, cholesterol, or diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have at least one of these: high blood pressure, diabetes, or high cholesterol
- Your condition is not well controlled (e.g., blood pressure above 140/90)
- You have been late refilling your medication for this condition in the last 6 months
- You have a cellphone
- You speak English or Spanish
- You are not in hospice or palliative care, and not in another clinical trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a text-message education program to help people living with HIV manage cardiovascular (heart and blood vessel) health. It may be helpful if you are 40 or older and can use a smartphone to receive messages.
This study uses artificial intelligence to analyze heart tests (ECGs) to help diagnose and predict outcomes for people with heart disease. It may lead to better and faster detection of heart conditions.
This study tests whether personalized text messages from an AI program can help people with type 2 diabetes become more physically active. If you have diabetes and are not as active as you'd like, this program might help you build a healthier routine.
This study tests if personalized text messages generated by artificial intelligence can help improve sleep. You may join if you have trouble sleeping and use a smartphone.
This study tests whether messages from a large language model (a type of AI) can help doctors prescribe the right medicines for heart failure. It may help people with heart failure get the best guideline-recommended treatments.
This study tests if an AI-powered system can help manage premature coronary artery disease in adults aged 18 to 45. It uses a smartphone app to support treatment and improve outcomes.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.